))
The importance of educating the public about cell and gene therapies
Manage episode 314556225 series 3291201
CCRM에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 CCRM 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
How can the regenerative medicine community create broader societal awareness?
Featuring:
Dr. Janet Rossant, President and Scientific Director, Gairdner Foundation
Dr. Phil Vanek, Chief Technology Officer, Gamma Biosciences
Drs. Rossant and Vanek discuss public awareness of cell and gene therapies, the importance of improving it, and how confusing and misleading claims made about unapproved stem cell treatments hinder our sector’s public education efforts. Join our guests and CCRM’s host, Krista Lamb to hear why regenerative medicine is at a real tipping point, both in terms of public awareness, and technologies that will transform patients’ lives.
Dr. Janet Rossant, President and Scientific Director, Gairdner Foundation
Dr. Phil Vanek, Chief Technology Officer, Gamma Biosciences
Drs. Rossant and Vanek discuss public awareness of cell and gene therapies, the importance of improving it, and how confusing and misleading claims made about unapproved stem cell treatments hinder our sector’s public education efforts. Join our guests and CCRM’s host, Krista Lamb to hear why regenerative medicine is at a real tipping point, both in terms of public awareness, and technologies that will transform patients’ lives.
Thanks for listening to Commercializing Living Therapies with CCRM. Spread the word about this episode by taking a screen cap on your device and posting it to social media using the hashtag #CCRMpodcast. Please leave us a review on your favourite streaming service. Find more episodes at ccrm.ca/podcast.
18 에피소드
공유
